The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis

BACKGROUND: Combined therapy with alendronate and calcitriol may have additive effects on bone density. An observational study was performed to evaluate the efficacy and safety of Maxmarvil, a combinative agent of alendronate (5 mg) and calcitriol (0.5 µg), and to identify factors associated with ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Hee-Won, Kim, Hyun-Ok, Kim, Young Sik, Sunwoo, Sung, Lee, Jung Ah, Lee, Hye-Ree, Kim, Byungsung, Kim, Dae Hyun, Choi, Youn Seon, Cheong, Yoo Seock, Yum, Keunsang, Yang, Yun Jun, Yu, Byung-Yeon, Cho, Chung Hwan, Park, Sat-Byul, Shin, Dong Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Family Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526717/
https://www.ncbi.nlm.nih.gov/pubmed/23267420
http://dx.doi.org/10.4082/kjfm.2012.33.6.346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526717/
https://www.ncbi.nlm.nih.gov/pubmed/23267420
http://dx.doi.org/10.4082/kjfm.2012.33.6.346

Ejemplares similares